A study investigating the efficiency of CGRP, PACAP, and VIP as migraine biomarkers using blood samples derived from chronic migraineurs, episodic migraineurs, and healthy controls revealed that VIP and PACAP could increase the risk of chronic migraines but not that of recurrent migraines. The gene discussed is ADCYAP1; the disease is migraine disorder.